Τρίτη 27 Αυγούστου 2019


Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints.
This article explores the known and the emerging areas of clinical research on patients with BRCAwt ovarian cancer. Expert opinion: Discovery of molecular changes tied to annotated disease information, along with an expanding array of pathway targets and targeted therapeutic agents, creates optimism and opportunity for women with ovarian cancer. Using precision oncology approaches, clinical researchers are, and will be, poised to select more effective treatments for ovarian cancer patients. ...
MedWorm Cancer & Oncology Research
2m
The effect of sampling procedures and day-to-day variations in metabolomics studies of biofluids.
In this study we examined the effect of sample collection and sample processing procedures on NMR measured serum lipoproteins and small-molecule metabolites in serum and urine, using a cohort of men diagnosed with either prostate cancer or benign prostatic hyperplasia. We determined day-to-day reliability of metabolites by systematic sample collection at two different days, in both fasting and non-fasting conditions. Study participants received prostate massage the first day to assess the differences...
MedWorm Cancer & Oncology Research
2m
High-sensitive electrochemiluminescent analysis based on co-reactive high-molecular polymer and dual catalysis to generate oxygen in situ.
Authors: Wang H, Song Y, Chai Y, Yuan R Abstract In this work, we found that polyethyleneimine (PEI), a widely applied organic high-molecular polymer, could act as a new co-reactant to obviously improve the electrochemiluminescence (ECL) of S2O82--O2 system. And owing to its abundant amine groups in the polymeric structure, PEI was further used to covalently crosslink with massive L-cysteine (L-Cys), an effective co-reactant of S2O82--O2 ECL system, to obtain a new co-reactive high-molecular...
MedWorm Cancer & Oncology Research
2m
Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS.
Authors: Qin W, Zhang Z, Qin R, Han J, Zhao R, Gu Y, Pan Y, Gu J, Ren S Abstract Accurate, simple and economical methods for quantifying N-glycans are continuously required for discovering disease biomarkers and quality control of biopharmaceuticals. Quantitative N-glycomics based on MS using exogenous isotopic labeling internal standards is promising as it is simple and accurate. However, it is largely hampered by the lack of available glycan internal standard libraries with good coverage...
MedWorm Cancer & Oncology Research
2m
Determination of cytidine modifications in human urine by liquid chromatography - Mass spectrometry analysis.
This study indicates that the urinary hydroxylmethylation modifications of hm5dC, hm5rC, and hm5rCm may serve as potential indicator of cancers. PMID: 31446947 [PubMed - in process] (Source: Analytica Chimica Acta)
MedWorm Cancer & Oncology Research
2m
Factors associated with human papillomavirus infection & ndash; findings from a cervical cancer screening program for female employees in Beijing
(Source: Cancer Management and Research)
MedWorm Cancer & Oncology Research
2m
microRNA-493 inhibits tongue squamous cell carcinoma oncogenicity via directly targeting HMGA2
(Source: OncoTargets and Therapy)
MedWorm Cancer & Oncology Research
2m
BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
(Source: OncoTargets and Therapy)
MedWorm Cancer & Oncology Research
2m
miR-1271 inhibits growth, invasion and epithelial & ndash;mesenchymal transition by targeting ZEB1 in ovarian cancer cells
(Source: OncoTargets and Therapy)
MedWorm Cancer & Oncology Research
2m
SNHG8 is upregulated in esophageal squamous cell carcinoma and directly sponges microRNA-411 to increase oncogenicity by upregulating KPNA2
(Source: OncoTargets and Therapy)
MedWorm Cancer & Oncology Research
2m
Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation miR-149-3p/RNF2 axis
(Source: OncoTargets and Therapy)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Research
2m
MicroRNA-30a-3p inhibits the progression of lung cancer via the PI3K/AKT by targeting DNA methyltransferase 3a
(Source: OncoTargets and Therapy)
MedWorm Cancer & Oncology Research
2m
PD-1 inhibitors dependent CD8+ T cells inhibit mouse colon cancer cell metastasis
(Source: OncoTargets and Therapy)
MedWorm Cancer & Oncology Research
2m
An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
(Source: OncoTargets and Therapy)
MedWorm Cancer & Oncology Research
2m
Cost-Effectiveness of [18F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma
Conclusion: Our comparative study of conventional MRI and [18F]FET PET revealed that the latter is a valuable tool for predicting the treatment responses of patients with glioblastomas to follow-up temozolomide maintenance treatment while considering its cost-effectiveness. Thus, [18F]FET PET scans enable clinical outcomes to be predicted accurately and at a low cost. Moreover, given the robustness of the data in the sensitivity analyses, the level of certainty of this outcome is acceptable. (Source:...
MedWorm Cancer & Oncology Research
2m
Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1
AbstractT cell receptor (TCR) gene-engineered T cells have shown promise in the treatment of melanoma and synovial cell sarcoma, but their application to epithelial cancers has been limited. The identification of novel therapeutic TCRs for the targeting of these tumors is important for the development of new treatments. Here, we describe the preclinical characterization of a TCR directed against Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1, encoded byCT83), a cancer germline antigen with frequent expression...
MedWorm Cancer & Oncology Research
2m
Cancers, Vol. 11, Pages 1258: Neurokinin-1 Receptor Antagonists against Hepatoblastoma
Authors: Miguel Muñoz Marisa Rosso Rafael Coveñas Hepatoblastoma (HB) is the most common malignant liver tumor that occurs during childhood. The prognosis of children with HB is favorable when a complete surgical resection of the tumor is possible, but for high-risk patients, the prognosis is much worse. New anti-HB strategies must be urgently developed. The undecapeptide substance P (SP) after binding to the neurokinin-1 receptor (NK-1R), regulates cancer cell proliferation, exerts...
MedWorm Cancer & Oncology Research
2m
Immunotherapy in People With HIV and Cancer
HIV infection increases the risk of cancer. HIV-associated lymphocytopenia and immune dysregulation permit immune evasion of oncogenic viruses and premalignant lesions. Various types of immunotherapy, including monoclonal antibodies, interferon, cytokines, immunomodulatory drugs (IMiDs), allogeneic hematopoietic stem cell transplant, and most importantly ART have shown efficacy in HIV-related cancer. Emerging data suggest that checkpoint inhibitors targeting the PD-1/PD-L1 pathway can be safe and...
MedWorm Cancer & Oncology Research
2m
Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment
Dendritic cell (DC)-based vaccines pulsed with high hydrostatic pressure (HHP)-inactivated tumor cells have been demonstrated to be a promising immunotherapy for solid tumors. We focused on sole injection of tumor cells that were inactivated by HHP and their combination with local radiotherapy (RTx) for in vivo induction of anti-tumor immune responses. HHP-treatment of tumor cells resulted in predominantly necrotic cells with degraded DNA. We confirmed that treatments at 200 MPa or higher completely...
MedWorm Cancer & Oncology Research
2m
Editorial: Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition
(Source: Frontiers in Oncology)
MedWorm Cancer & Oncology Research
2m
TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
In conclusion, we uncovered an unexpected novel role of TRAIL-R4 in PDAC cells. In contrast to its known pro-tumoral, anti-apoptotic function, TRAIL-R4 augments the anti-tumoral cytotoxic activity of γδ T cells. (Source: Frontiers in Immunology)
MedWorm Cancer & Oncology Research
3m
Cancers, Vol. 11, Pages 1259: Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
Authors: Carlo Buonerba Simona Iaccarino Pasquale Dolce Martina Pagliuca Michela Izzo Luca Scafuri Ferdinando Costabile Vittorio Riccio Dario Ribera Brigitta Mucci Simone Carrano Fernanda Picozzi Davide Bosso Luigi Formisano Roberto Bianco Sabino De Placido Giuseppe Di Lorenzo Some commonly available patient or disease characteristics may be associated with progression-free survival (PFS) and overall survival (OS) in EGFR-mutant non-small cell...
MedWorm Cancer & Oncology Research
3m
Management of Steroid-Refractory Immune-Related Adverse Events
 The increasing utilization of these immune checkpoint inhibitors has presented new of immune-related adverse events  that have proven to be extremely challenging to manage. (Source: CancerNetwork)
MedWorm Cancer & Oncology Top 20
11h
Gilteritinib Changes AML Landscape
The US Food and Drug Administration recently approved gilteritinib (Xospata), in addition to final trial data from the phase 3 ADMIRAL trial, making it the new standard of care for acute myeloid leukemia. (Source: CancerNetwork)
MedWorm Cancer & Oncology Top 20
11h
Targeting the Sanctuary Site: Options when Breast Cancer Metastasizes to the Brain
Brain metatstasis is common in breast cancer and often has a poor prognosis, but there are several ways to manage brain metastasis in breast cancer including focal therapies as well as systemic options for specific populations, including emerging and novel therapies. (Source: CancerNetwork)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Top 20
11h
There's a Troubling Rise in Colorectal Cancer Among Young Adults
Some experts blame our modern, sugary diet, while others think that gut microbiome changes and sedentary lifestyles may play a role. Altogether, the causes are far from clear. (Source: The Scientist)
MedWorm Cancer & Oncology Top 20
14h
Mesothelioma Study Explores New Treatment When Chemotherapy Fails
A clinical trial is exploring whether a novel immunotherapy/antiangiogenic combination can serve as an effective second-line treatment for pleural mesothelioma. Early indications of the four-center, phase II clinical trial are positive. The combination involves nivolumab (Opdivo) , a well-known immunotherapy drug, and ramucirumab (Cyramza), a therapy drug that blocks the formation of blood vessels needed for new tumor growth. The Food and Drug Administration approved both drugs for the treatment...
MedWorm Cancer & Oncology Top 20
21h
Upstate shines light on bladder cancer
Blue Light Cystoscopy helps doctors better detect and diagnose cancerous tumors in the bladder. (Source: SUNY Upstate Medical)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Top 20
21h
My Special AFLAC Duck: A Gold Standard For CSR Programs
The " My Special Aflac Duck " in which the company provides pediatric cancer patients with a robotic " smart " duck to help them through painful treatments is reviewed. The initiative is a feel-good success story that follows principles of effective CSR initiatives. (Source: Forbes.com Healthcare News)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Top 20
23h
Cancer doctors don't focus on lifestyle risks
(Reuters Health) - Cancer specialists only rarely advise patients on lifestyle changes that could improve overall health and possibly also reduce the risk of recurrence, a new survey suggests. (Source: Reuters: Health)
MedWorm Cancer & Oncology Top 20
23h
Screen At-risk Women for BRCA-related Cancer
The U.S. Preventive Services Task Force recently posted a final recommendation statement on risk assessment, genetic counseling and genetic testing for BRCA-related cancer in women. (Source: AAFP News)
MedWorm Cancer & Oncology Top 20
23h
FDA: Men Should Be Included in Breast Cancer Clinical Trials
MONDAY, Aug. 26, 2019 -- Men should be included in clinical trials of new breast cancer treatments, the U.S. Food and Drug Administration says. " Less than 1 percent of all breast cancer cases occur in men, but men are more likely to be diagnosed at... (Source: Drugs.com - Pharma News)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Top 20
23h
Stomach cancer: Eight risk factors to watch out for
STOMACH cancer symptoms can be vague and easy to mistake for other less serious conditions. Unfortunately, it tends to get diagnosed once it has advanced. Understanding the risk factors is essential to improving outcomes. (Source: Daily Express - Health)
MedWorm Cancer & Oncology Top 20
23h
FDA urges that men be included in breast cancer trials
The U.S. Food and Drug Administration (FDA) on August 26 released a draft guidance...Read more on AuntMinnie.comRelated Reading: Men need breast cancer screening too SBI: Don't overlook men when it comes to breast cancer FDG-PET/CT helps stage men with breast cancer, too Male breast masses require careful investigation Mammography, US help diagnose male breast cancer (Source: AuntMinnie.com Headlines)
MedWorm Cancer & Oncology Top 20
23h
Childhood cancer survivors 10 times more likely to develop heart failure
Childhood cancer survivors have 10 times the risk of developing heart failure compared to children without cancer, a new study says. (Source: Health News - UPI.com)
MedWorm Cancer & Oncology Top 20
23h
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors
MONDAY, Aug. 26, 2019 -- Survivors of childhood cancer have an increased risk for all subtypes of cardiovascular disease (CVD), according to a research letter published online Aug. 26 in Circulation. Ashna Khanna, from the University of Toronto, and... (Source: Drugs.com - Pharma News)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Top 20
23h
Childhood Cancer Survivors Struggle With Heart Troubles
MONDAY, Aug. 26, 2019 -- The treatments that childhood cancer patients receive often save their lives, but they also make survivors prone to heart troubles, a new study finds. For the study, researchers examined heart disease rates in nearly 7,300... (Source: Drugs.com - Daily MedNews)
MedWorm Cancer & Oncology Top 20
1d
Medical News Today: Can acupressure relieve headaches?
Acupressure is a form of complementary or alternative medicine. Read about research on the efficacy of acupressure for headache, and learn some simple acupressure techniques to try at home. (Source: Health News from Medical News Today)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Complementary Medicine
11h

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου